These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4717493

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM, Cheng WC, Tomeu EJ, Renk CM.
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract] [Full Text] [Related]

  • 43. Functional heterogeneity of antibody to penicilloyl coated erythrocytes.
    Watson KC.
    Immunology; 1971 Mar; 20(3):381-90. PubMed ID: 5551359
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
    Miyama A, Kato T, Yokoo J, Kashiba S.
    Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
    [Abstract] [Full Text] [Related]

  • 46. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds.
    Vyas GN, Rao KR, Ibrahim AB.
    Science; 1972 Dec 22; 178(4067):1300-1. PubMed ID: 4118259
    [Abstract] [Full Text] [Related]

  • 47. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE, Spitzer RE.
    J Immunol; 1974 Jan 22; 112(1):56-62. PubMed ID: 4130153
    [No Abstract] [Full Text] [Related]

  • 48. Isolation and characterization of Guinea pig properidin.
    Nicholson A, Austen KF.
    J Immunol; 1977 Jan 22; 118(1):103-8. PubMed ID: 830742
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Isolation and characterization of a trypsin-cleaved fragment derived from the third component of guinea pig complement bound to zymosan.
    Takahashi M, Takahashi S, Motonishi K.
    Jpn J Exp Med; 1974 Dec 22; 44(6):547-51. PubMed ID: 4477225
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Chemical modification of the beta adrenergic receptors coupled with adenylate cyclase by disulfide bridge-reducing agents.
    Lucas M, Hanoune J, Bockaert J.
    Mol Pharmacol; 1978 Mar 22; 14(2):227-36. PubMed ID: 205769
    [No Abstract] [Full Text] [Related]

  • 55. Studies on rat complement. I. Immune adherence and immune hemolysis activities of rat serum.
    Sakamoto M.
    Jpn J Exp Med; 1975 Jun 22; 45(3):183-9. PubMed ID: 1177359
    [Abstract] [Full Text] [Related]

  • 56. Detection of human lymphocytes bearing complement receptors after in vitro modification with mercaptoethanol.
    Daniels RP, Rowlands DT.
    Transplantation; 1974 Jan 01; 17(1):126-8. PubMed ID: 4855589
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.
    Gaither TA, Alling DW, Frank MM.
    J Immunol; 1974 Aug 01; 113(2):574-83. PubMed ID: 4210883
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.